These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2130001)

  • 1. Quantitative effect of roxithromycin and rifampicin on mucoid cultures from directly plated sputum of cystic fibrosis patients chronically colonized with Pseudomonas aeruginosa.
    Dupont MJ; Lapointe JR
    Drugs Exp Clin Res; 1990; 16(12):597-605. PubMed ID: 2130001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucoid and pigmentation characters can be suppressed by non-anti-Pseudomonas aeruginosa antibiotics in cystic fibrosis: a report of promising preliminary results.
    Lapointe JR; Bourget C; Lafleur L; Lagacé J; Montplaisir S
    Drugs Exp Clin Res; 1988; 14(8):501-10. PubMed ID: 3150349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on Pseudomonas aeruginosa alginate expression of direct plating and culture of fresh cystic fibrosis sputum on to pseudomonas isolation agar containing subinhibitory concentrations of roxithromycin and rifampicin.
    Dupont MJ; Lapointe JR
    J Antimicrob Chemother; 1995 Jul; 36(1):231-6. PubMed ID: 8537272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
    Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S
    N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media.
    Perry JD; Laine L; Hughes S; Nicholson A; Galloway A; Gould FK
    J Antimicrob Chemother; 2008 May; 61(5):1057-61. PubMed ID: 18316821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients.
    Laine L; Perry JD; Lee J; Oliver M; James AL; De La Foata C; Halimi D; Orenga S; Galloway A; Gould FK
    J Cyst Fibros; 2009 Mar; 8(2):143-9. PubMed ID: 19097827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
    Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
    Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with mucoid transition of Pseudomonas aeruginosa in cystic fibrosis patients.
    Martha B; Croisier D; Fanton A; Astruc K; Piroth L; Huet F; Chavanet P
    Clin Microbiol Infect; 2010 Jun; 16(6):617-23. PubMed ID: 20002106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing.
    Foweraker JE; Laughton CR; Brown DF; Bilton D
    J Antimicrob Chemother; 2005 Jun; 55(6):921-7. PubMed ID: 15883175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucoid Escherichia coli in cystic fibrosis.
    Macone AB; Pier GB; Pennington JE; Matthews WJ; Goldmann DA
    N Engl J Med; 1981 Jun; 304(24):1445-9. PubMed ID: 6785645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis.
    Karpati F; Jonasson J
    Mol Cell Probes; 1996 Dec; 10(6):397-403. PubMed ID: 9025076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
    Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
    Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of five antibiotics on adhesion and haemagglutinating properties of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Marty N; Lapchine L; Dournes JL; Agueda L; Chabanon G
    Drugs Exp Clin Res; 1988; 14(10):635-43. PubMed ID: 3149932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis.
    Lagacé J; Mercier J; Fréchette M; Fournier D; Dubreuil M; Lamarre A; Lapointe JR; Montplaisir S
    J Clin Lab Immunol; 1989 Sep; 30(1):7-11. PubMed ID: 2534928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: a phase I feasibility study.
    Kollberg H; Carlander D; Olesen H; Wejåker PE; Johannesson M; Larsson A
    Pediatr Pulmonol; 2003 Jun; 35(6):433-40. PubMed ID: 12746939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence ability of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis to two different epithelial cell lines.
    Vranes J; Tjesić-Drinković D; Zulj I; Kruzić V; Turković B; Marić S
    Coll Antropol; 2004 Dec; 28(2):675-80. PubMed ID: 15666599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
    De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
    J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms.
    Alkawash MA; Soothill JS; Schiller NL
    APMIS; 2006 Feb; 114(2):131-8. PubMed ID: 16519750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.